Ịgba ọgwụ mgbochi ọrịa bụ ngwa ọgụ maka ụwa iji merie ọrịa oyi baa okpueze ọhụrụ.Ka ndị mmadụ na-enwe ike mezue ịgba ọgwụ mgbochi ọrịa ngwa ngwa, ka ọ ga-aka mma ka mba dị iche iche chịkwaa ọrịa a ngwa ngwa ma zere mgbasa nke nje n'ọtụtụ buru ibu.

Dị ka akụkọ Bloomberg si kwuo na 3rd, ọnụ ọgụgụ nke ịgba ọgwụ mgbochi ọrịa zuru ụwa ọnụ eruola ijeri 2 ijeri doses, na o were ihe karịrị ọnwa 6 iji nweta ihe a dị ịrịba ama.Ọnụọgụ ịgba ọgwụ mgbochi ọrịa 75% bụ ọnụ ụzọ iji nweta mgbochi igwe.N'ọnụego dị ugbu a, ọ ga-ewe ihe dịka ọnwa 9 ịgba ọgwụ mgbochi 75% nke ndị bi n'ụwa.

N'ihe dị na June 19, Mahadum Oxford Worldwa anyị na ọnụ ọgụgụ data akọpụtala mkpokọta 2625200905 nke ọgwụ mgbochi nje virus ọhụrụ n'ụwa niile, yana ọnụ ọgụgụ inoculation nke 21.67%.Mgbalị imepụta ọgwụ COVID-19 dị mma ma dịkwa irè n'ụwa niile na-amịpụta mkpụrụ.Ugbu a, ihe fọrọ nke nta ka ọ bụrụ ọgwụ mgbochi 20 ka akwadoro n'ụwa nile;ọtụtụ ndị ọzọ ka na-emepe emepe.

Ọgwụ ndị ọzọ na-abịa

Isi ihe kpatara COVAX tụfuru ebumnuche ya ruo ugbu a bụ na o nwere obere ego n'afọ gara aga iji zụta ọgwụ mgbochi, yana dabere na Serum Institute of India inye doses ruo mgbe ụlọ ọrụ ndị ọzọ na-enye ngwaahịa egosipụtara na ọnụ ahịa mbelata.MaSerumkwụsịrị mbupụ ọgwụ ndị e kwere ná nkwa na March, mgbe ikpe COVID-19 na India gbawara.Mwapụta ahụ abawanyela ugbu a, ụlọ ọrụ ahụ akwalitela mmepụta ya site na ihe dị ka nde 60 nke ọgwụ mgbochi AstraZeneca kwa ọnwa ruo nde 100 n'ọnwa a.Ike nwere ike iru 250 nde doses kwa ọnwa na njedebe nke afọ, ụlọ ọrụ na-agwa Science.Ndị isi COVAX nwere olile anya na ụlọ ọrụ ahụ nwere ike ịmaliteghachi mbupụ ozugbo Septemba.

Novavax, nke kwuputara na ogwu ya nwere90% arụmọrụna nnukwu ikpenke gọọmentị US kwadoro, esonyelakwa na Serum.Ọnụ, ụlọ ọrụ ndị ahụ nwere ike iweta 1.1 ijeri doses na COVAX na 2022 nke nwere ike ịmalite ịbanye na ogwe aka ọdịda a ma ọ bụrụ na Novavax jab na-agafe ndị na-achịkwa.Usoro ndu E, onye nrụpụta India ọzọ, na-ezube ịnye COVAX nde 200 nke ọgwụ mgbochi Johnson & Johnson enyerelarị ikike, nke kwesịrị ịmalite n'ahịrị mmepụta na Septemba.

Ọgwụ mgbochi nke Pfizer-BioNTech mmekorita na Moderna mepụtara nwere ike rụọ nnukwu ọrụ na COVAX karịa ka a tụrụ anya ya.Companieslọ ọrụ ndị a na-eji RNA ozi na-eme ọgwụ mgbochi, nke chọrọ obere okpomọkụ n'oge njem wee nwee ike ịdị ọhụrụ na friji oge niile otu ọnwa.Amamihe ọdịnala kwenyere ogologo oge na ihe ndị a chọrọ, yana ọnụ ahịa ọnụ ahịa ọgwụ mgbochi, pụtara na enweghị ike iji ha mee ihe n'ọtụtụ ụwa.Mana na 10 June, gọọmentị US - nke nyere COVAX ijeri $2 - kwupụtara na ọ ga-enye COVAX nde 200 nke ọgwụ mgbochi Pfizer n'afọ a yana nde 300 ọzọ site na June 2022, yanaUPS Foundationinye onyinye friza nye mba ndị chọrọ enyemaka na nchekwa.(O dochaghị anya ma onyinye a nwere ike ịbụ n'ọnọdụ nkwa gọọmentị US inye COVAX ijeri $2 ọzọ.) Moderna wepụrụ nkwekọrịta ya na COVAX iji ree ihe ruru nde 500 nke ọgwụ mgbochi ya na njedebe nke 2022.

Nnukwu ọgwụ mgbochi nwere ike ịbịa na COVAX site na isi mmalite ọzọ: China.N'oge na-adịbeghị anya WHO nyere ndị China abụọ na-emepụta "ndepụta iji ihe mberede" - nke achọrọ maka COVAX.SinopharmnaỤlọ ọrụ Sinovac Biotech, nke ewepụtala ihe dị ka ọkara nke ọgwụ mgbochi niile a na-enye gburugburu ụwa ruo taa.Berkley na-ekwu na ndị otu ya na Gavi, nke na-azụta ihe maka COVAX, na-ekwurịta okwu na ụlọ ọrụ abụọ ahụ.